BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3681045)

  • 1. Effect of thermochemotherapy on the development of spontaneous lung metastases.
    Ando K; Urano M; Kenton L; Kahn J
    Int J Hyperthermia; 1987; 3(5):453-8. PubMed ID: 3681045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thermochemotherapy (combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma.
    Urano M; Kim MS; Kahn J; Kenton LA; Li ML
    Cancer Res; 1985 Sep; 45(9):4162-6. PubMed ID: 4028008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between alkylating agent and cis-platin with moderate local hyperthermia: the effect of multidrug chemotherapy in an animal system.
    Matsushita S; Reynolds R; Urano M
    Int J Hyperthermia; 1993; 9(2):285-96. PubMed ID: 8468510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thermoimmunotherapy with OK-432 on the development of spontaneous lung metastases in mice.
    Taradi SK; Taradi M; Urano M
    Int J Hyperthermia; 1992; 8(2):221-6. PubMed ID: 1573311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma.
    Teicher BA; Herman TS; Menon K; Korbut TT
    Int J Hyperthermia; 1992; 8(6):783-94. PubMed ID: 1479204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermochemotherapy (combined cyclophosphamide and hyperthermia) with or without hyperglycemia as an adjuvant to radiotherapy.
    Urano M; Kahn J; Kenton LA
    Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):45-50. PubMed ID: 3943991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermochemotherapy-induced resistance to cyclophosphamide.
    Urano M; Kahn J; Kenton LA
    Br J Cancer; 1988 Mar; 57(3):295-7. PubMed ID: 3355769
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyperglycemia on thermochemotherapy of a spontaneous murine fibrosarcoma.
    Urano M; Kim MS
    Cancer Res; 1983 Jul; 43(7):3041-4. PubMed ID: 6850614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bleomycin administered in combination with hyperthermia on a C3H mouse fibrosarcoma.
    Urano M; Kahn J
    Int J Hyperthermia; 1989; 5(3):377-82. PubMed ID: 2470841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between adriamycin cytotoxicity and hyperthermia: growth-phase-dependent thermal sensitization.
    Urano M; Begley J; Reynolds R
    Int J Hyperthermia; 1994; 10(6):817-26. PubMed ID: 7884241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal enhancement of the effect of ifosfamide against a spontaneous murine fibrosarcoma, FSa-II.
    Kuroda M; Urano M; Reynolds R
    Int J Hyperthermia; 1997; 13(1):125-31. PubMed ID: 9024933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel and hyperthermia: factors that modify thermal enhancement.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    J Surg Oncol; 2004 Oct; 88(1):14-20. PubMed ID: 15384091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage produced by combined hyperglycemia and hyperthermia in two mouse fibrosarcoma tumors in vivo.
    Murray D; Milas L; Meyn RE
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1679-82. PubMed ID: 6480453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of melphalan by systemic hyperthermia in mice: therapeutic gain for mouse lung microtumours.
    Honess DJ; Bleehen NM
    Int J Hyperthermia; 1985; 1(1):57-68. PubMed ID: 3837082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA; Pfeffer MR; Alvarez Sotomayor E; Herman TS
    Int J Hyperthermia; 1991; 7(5):773-84. PubMed ID: 1834752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma.
    Kuroda M; Urano M; Nishimura Y; Reynolds R
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subrenal capsule assay applied to examine the sensitivity of allogenic mouse fibrosarcoma to hyperthermia, chemotherapeutic drugs or combined treatment.
    Sato S; Ootsuyama A; Hamada M; Tanooka H
    Int J Hyperthermia; 1987; 3(2):177-82. PubMed ID: 3110329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of whole-body hyperthermia on cell survival, metastasis frequency, and host immunity in moderately and weakly immunogenic murine tumors.
    Urano M; Rice L; Epstein R; Suit HD; Chu AM
    Cancer Res; 1983 Mar; 43(3):1039-43. PubMed ID: 6825078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.